Cytoreductive radical prostatectomy (cRP) in the management of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC).

被引：0
|
作者：
Heidenreich, Axel
Rieger, Constantin
Kastner, Lucas
Seelemeyer, Felix
Pfister, David
机构：
[1] Univ Hosp Cologne, Dept Urol, Cologne, Germany
[2] Univ Clin Cologne, Dept Urol, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE-NAIVE, METASTATIC PROSTATE CANCER (MPCA).
    Heidenreich, Axel
    Karnes, Jeff. R.
    Briganti, Alberto
    Shariat, Shahrokh
    Porres, Daniel
    Fossati, Nicola
    Montorsi, Francesco
    Suardi, Nazareno
    Pfister, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E721 - E721
  • [22] NEWLY-DIAGNOSED LOW-VOLUME METASTATIC PROSTATE CANCER; IS THERE A PLACE FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY?
    De Bleser, Elise
    Lumen, Nicolaas
    Buelens, Sarah
    Verla, Wesley
    Claeys, Wietse
    Fonteyne, Valerie
    Verbeke, Sofie
    Villeirs, Geert
    De Man, Kathia
    Rottey, Sylvie
    Van Praet, Charles
    Decaestecker, Karel
    Ost, Piet
    JOURNAL OF UROLOGY, 2021, 206 : E415 - E416
  • [23] Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
    Yuh, Bertram E.
    Kwon, Young Suk
    Shinder, Brian M.
    Singer, Eric A.
    Jang, Thomas L.
    Kim, Sinae
    Stein, Mark N.
    Mayer, Tina
    Ferrari, Anna
    Lee, Nara
    Parikh, Rahul R.
    Ruel, Nora
    Kim, Wun-Jae
    Horie, Shigeo
    Byun, Seok-Soo
    Ahlering, Thomas E.
    Kim, Isaac Yi
    PROSTATE INTERNATIONAL, 2019, 7 (03) : 102 - 107
  • [24] COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED HORMONE-SENSITIVE METASTATIC PROSTATE CANCER
    Pelloux-Prayer, R.
    Schiele, P.
    Oudard, S.
    Gravis, G.
    Kleinclauss, F.
    Crehange, G.
    Hennequin, C.
    Morgans, A.
    Geoffrois, L.
    Limat, S.
    Thiery-Vuillemin, A.
    Nerich, V
    VALUE IN HEALTH, 2022, 25 (01) : S113 - S113
  • [25] AUO First-line Therapy for metastatic hormone-sensitive Prostate Cancer (mHSPC)
    Rexer, H.
    Feyerabend, S.
    Graefen, M.
    UROLOGIE, 2023, 62 (04): : 441 - 442
  • [26] Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
    Pelloux-Prayer, Remi
    Schiele, Philomene
    Oudard, Stephane
    Gravis, Gwenaelle
    Kleinclauss, Francois
    Crehange, Gilles
    Hennequin, Christophe
    Morgans, Alicia K.
    Geoffrois, Lionel
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    Nerich, Virginie
    CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : E326 - E333
  • [27] Efficacy of bi-weekly docetaxel in hormone-sensitive metastatic prostate cancer (mHSPC).
    Lombana Quinonez, Milton Alberto
    Milena Torres, Ana
    Gonzalez, Guido
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Cytoreductive, radical prostatectomy in metastatic prostate cancer
    Chaloupka, M.
    Herlemann, A.
    Spek, A.
    Gratzke, C.
    Stief, C.
    UROLOGE, 2017, 56 (11): : 1430 - 1434
  • [29] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [30] PSMA PET/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC)
    Henriquez, Ivan
    Malave, Barbara
    Campos, Fernando Lopez
    Hidalgo, Elena Centelles
    Muelas, Rodrigo
    Ferrer, Carlos
    Munoz-Rodriguez, Jesus
    Villamon, Agustina Mendez
    Pascual, Maria Cerrolaza
    Badia, Joan
    Fuertes, Jordi
    Hinojosa-Salas, Percy
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 706 - 715
12345